Like Investing in the Internet in 1990

Wired magazine is saying this small company “could be the [next] Intel”…
And it’s easy to see why.
They’re both microchip companies.
They’re both from Silicon Valley.
And in a few years’ time, they could BOTH be in the stock market Hall of Fame…
The only difference is this new company is at the start of its journey … with most of its profit potential still to be realized…
Intrigued?
Regards,

Adam O'Dell
Chief Investment Strategist, Money & Markets

Don’t Stop Here

More To Explore

GOSS: Class Action Alert for Gossamer Bio Investors!

Overview and Background Gossamer Bio (NASDAQ: GOSS) is a clinical-stage biopharmaceutical company focused on developing seralutinib, an inhaled therapy for pulmonary arterial hypertension (PAH) (robbinsllp.com)